Bayer HealthCare / Press

Bayer’s Adempas® (riociguat) Approved for the Treatment of Two Life-Threatening Forms of Pulmonary Hypertension in the EU

Bayer announced that Adempas® (riociguat) has been approved by the European Commission for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.
    more

  • TV Footage

    In this section you can find videos for editorial coverage.
    more

Bayer HealthCare Links


http://press.healthcare.bayer.com/en/press/index.php

Copyright © Bayer HealthCare AG